Global Hemostat Powder Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Hemostat Powder Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.
Hemostat powder is product in form of powder.

According to APO Research, The global Hemostat Powder market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Hemostat Powder is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Hemostat Powder is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Hemostat Powder is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Hemostat Powder include Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring, Gelita Medical, Ferrosan Medical Devices, Baxter, Celox and Equimedical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hemostat Powder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostat Powder.
The Hemostat Powder market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostat Powder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Johnson & Johnson
C. R. Bard
Pfizer
CSL Behring
Gelita Medical
Ferrosan Medical Devices
Baxter
Celox
Equimedical
Medira
Biocer
Hemostasis
MBP
Hemostat Powder segment by Type

Gelatin
Fibrin
Cellulose
Others
Hemostat Powder segment by Application

Surgical Wound Care
General Wound Care
Hemostat Powder Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostat Powder market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemostat Powder and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostat Powder.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemostat Powder manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Hemostat Powder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Hemostat Powder Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Hemostat Powder Sales Estimates and Forecasts (2019-2030)
1.3 Hemostat Powder Market by Type
1.3.1 Gelatin
1.3.2 Fibrin
1.3.3 Cellulose
1.3.4 Others
1.4 Global Hemostat Powder Market Size by Type
1.4.1 Global Hemostat Powder Market Size Overview by Type (2019-2030)
1.4.2 Global Hemostat Powder Historic Market Size Review by Type (2019-2024)
1.4.3 Global Hemostat Powder Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Hemostat Powder Sales Breakdown by Type (2019-2024)
1.5.2 Europe Hemostat Powder Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Hemostat Powder Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Hemostat Powder Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Hemostat Powder Sales Breakdown by Type (2019-2024)
2 Global Market Dynamics
2.1 Hemostat Powder Industry Trends
2.2 Hemostat Powder Industry Drivers
2.3 Hemostat Powder Industry Opportunities and Challenges
2.4 Hemostat Powder Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Hemostat Powder Revenue (2019-2024)
3.2 Global Top Players by Hemostat Powder Sales (2019-2024)
3.3 Global Top Players by Hemostat Powder Price (2019-2024)
3.4 Global Hemostat Powder Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Hemostat Powder Key Company Manufacturing Sites & Headquarters
3.6 Global Hemostat Powder Company, Product Type & Application
3.7 Global Hemostat Powder Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Hemostat Powder Market CR5 and HHI
3.8.2 Global Top 5 and 10 Hemostat Powder Players Market Share by Revenue in 2023
3.8.3 2023 Hemostat Powder Tier 1, Tier 2, and Tier 3
4 Hemostat Powder Regional Status and Outlook
4.1 Global Hemostat Powder Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Hemostat Powder Historic Market Size by Region
4.2.1 Global Hemostat Powder Sales in Volume by Region (2019-2024)
4.2.2 Global Hemostat Powder Sales in Value by Region (2019-2024)
4.2.3 Global Hemostat Powder Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Hemostat Powder Forecasted Market Size by Region
4.3.1 Global Hemostat Powder Sales in Volume by Region (2025-2030)
4.3.2 Global Hemostat Powder Sales in Value by Region (2025-2030)
4.3.3 Global Hemostat Powder Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Hemostat Powder by Application
5.1 Hemostat Powder Market by Application
5.1.1 Surgical Wound Care
5.1.2 General Wound Care
5.2 Global Hemostat Powder Market Size by Application
5.2.1 Global Hemostat Powder Market Size Overview by Application (2019-2030)
5.2.2 Global Hemostat Powder Historic Market Size Review by Application (2019-2024)
5.2.3 Global Hemostat Powder Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Hemostat Powder Sales Breakdown by Application (2019-2024)
5.3.2 Europe Hemostat Powder Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Hemostat Powder Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Hemostat Powder Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Hemostat Powder Sales Breakdown by Application (2019-2024)
6 Company Profiles
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Comapny Information
6.1.2 Johnson & Johnson Business Overview
6.1.3 Johnson & Johnson Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson Hemostat Powder Product Portfolio
6.1.5 Johnson & Johnson Recent Developments
6.2 C. R. Bard
6.2.1 C. R. Bard Comapny Information
6.2.2 C. R. Bard Business Overview
6.2.3 C. R. Bard Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.2.4 C. R. Bard Hemostat Powder Product Portfolio
6.2.5 C. R. Bard Recent Developments
6.3 Pfizer
6.3.1 Pfizer Comapny Information
6.3.2 Pfizer Business Overview
6.3.3 Pfizer Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Hemostat Powder Product Portfolio
6.3.5 Pfizer Recent Developments
6.4 CSL Behring
6.4.1 CSL Behring Comapny Information
6.4.2 CSL Behring Business Overview
6.4.3 CSL Behring Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CSL Behring Hemostat Powder Product Portfolio
6.4.5 CSL Behring Recent Developments
6.5 Gelita Medical
6.5.1 Gelita Medical Comapny Information
6.5.2 Gelita Medical Business Overview
6.5.3 Gelita Medical Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Gelita Medical Hemostat Powder Product Portfolio
6.5.5 Gelita Medical Recent Developments
6.6 Ferrosan Medical Devices
6.6.1 Ferrosan Medical Devices Comapny Information
6.6.2 Ferrosan Medical Devices Business Overview
6.6.3 Ferrosan Medical Devices Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ferrosan Medical Devices Hemostat Powder Product Portfolio
6.6.5 Ferrosan Medical Devices Recent Developments
6.7 Baxter
6.7.1 Baxter Comapny Information
6.7.2 Baxter Business Overview
6.7.3 Baxter Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Baxter Hemostat Powder Product Portfolio
6.7.5 Baxter Recent Developments
6.8 Celox
6.8.1 Celox Comapny Information
6.8.2 Celox Business Overview
6.8.3 Celox Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Celox Hemostat Powder Product Portfolio
6.8.5 Celox Recent Developments
6.9 Equimedical
6.9.1 Equimedical Comapny Information
6.9.2 Equimedical Business Overview
6.9.3 Equimedical Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Equimedical Hemostat Powder Product Portfolio
6.9.5 Equimedical Recent Developments
6.10 Medira
6.10.1 Medira Comapny Information
6.10.2 Medira Business Overview
6.10.3 Medira Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Medira Hemostat Powder Product Portfolio
6.10.5 Medira Recent Developments
6.11 Biocer
6.11.1 Biocer Comapny Information
6.11.2 Biocer Business Overview
6.11.3 Biocer Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Biocer Hemostat Powder Product Portfolio
6.11.5 Biocer Recent Developments
6.12 Hemostasis
6.12.1 Hemostasis Comapny Information
6.12.2 Hemostasis Business Overview
6.12.3 Hemostasis Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hemostasis Hemostat Powder Product Portfolio
6.12.5 Hemostasis Recent Developments
6.13 MBP
6.13.1 MBP Comapny Information
6.13.2 MBP Business Overview
6.13.3 MBP Hemostat Powder Sales, Revenue and Gross Margin (2019-2024)
6.13.4 MBP Hemostat Powder Product Portfolio
6.13.5 MBP Recent Developments
7 North America by Country
7.1 North America Hemostat Powder Sales by Country
7.1.1 North America Hemostat Powder Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Hemostat Powder Sales by Country (2019-2024)
7.1.3 North America Hemostat Powder Sales Forecast by Country (2025-2030)
7.2 North America Hemostat Powder Market Size by Country
7.2.1 North America Hemostat Powder Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Hemostat Powder Market Size by Country (2019-2024)
7.2.3 North America Hemostat Powder Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Hemostat Powder Sales by Country
8.1.1 Europe Hemostat Powder Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Hemostat Powder Sales by Country (2019-2024)
8.1.3 Europe Hemostat Powder Sales Forecast by Country (2025-2030)
8.2 Europe Hemostat Powder Market Size by Country
8.2.1 Europe Hemostat Powder Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Hemostat Powder Market Size by Country (2019-2024)
8.2.3 Europe Hemostat Powder Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Hemostat Powder Sales by Country
9.1.1 Asia-Pacific Hemostat Powder Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Hemostat Powder Sales by Country (2019-2024)
9.1.3 Asia-Pacific Hemostat Powder Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Hemostat Powder Market Size by Country
9.2.1 Asia-Pacific Hemostat Powder Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Hemostat Powder Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Hemostat Powder Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Hemostat Powder Sales by Country
10.1.1 Latin America Hemostat Powder Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Hemostat Powder Sales by Country (2019-2024)
10.1.3 Latin America Hemostat Powder Sales Forecast by Country (2025-2030)
10.2 Latin America Hemostat Powder Market Size by Country
10.2.1 Latin America Hemostat Powder Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Hemostat Powder Market Size by Country (2019-2024)
10.2.3 Latin America Hemostat Powder Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Hemostat Powder Sales by Country
11.1.1 Middle East and Africa Hemostat Powder Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Hemostat Powder Sales by Country (2019-2024)
11.1.3 Middle East and Africa Hemostat Powder Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Hemostat Powder Market Size by Country
11.2.1 Middle East and Africa Hemostat Powder Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Hemostat Powder Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Hemostat Powder Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Hemostat Powder Value Chain Analysis
12.1.1 Hemostat Powder Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Hemostat Powder Production Mode & Process
12.2 Hemostat Powder Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Hemostat Powder Distributors
12.2.3 Hemostat Powder Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings